These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24304921)

  • 21. Clinical applications of cost analysis of diabetic macular edema treatments.
    Smiddy WE
    Ophthalmology; 2012 Dec; 119(12):2558-62. PubMed ID: 23062655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SF-6D utility values for the better- and worse-seeing eye for health states based on the Snellen equivalent in patients with age-related macular degeneration.
    Visser MS; Amarakoon S; Missotten T; Timman R; Busschbach JJ
    PLoS One; 2017; 12(2):e0169816. PubMed ID: 28225799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EQ-5D-Derived Health State Utility Values in Hematologic Malignancies: A Catalog of 796 Utilities Based on a Systematic Review.
    Golicki D; Jaśkowiak K; Wójcik A; Młyńczak K; Dobrowolska I; Gawrońska A; Basak G; Snarski E; Hołownia-Voloskova M; Jakubczyk M; Niewada M
    Value Health; 2020 Jul; 23(7):953-968. PubMed ID: 32762998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.
    Virgili G; Menchini F; Murro V; Peluso E; Rosa F; Casazza G
    Cochrane Database Syst Rev; 2011 Jul; (7):CD008081. PubMed ID: 21735421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results after lens extraction in patients with diabetic retinopathy: early treatment diabetic retinopathy study report number 25.
    Chew EY; Benson WE; Remaley NA; Lindley AA; Burton TC; Csaky K; Williams GA; Ferris FL
    Arch Ophthalmol; 1999 Dec; 117(12):1600-6. PubMed ID: 10604663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of ranibizumab and aflibercept to treat diabetic macular edema from a US perspective: analysis of 2-year Protocol T data.
    Holekamp N; Duff SB; Rajput Y; Garmo V
    J Med Econ; 2020 Mar; 23(3):287-296. PubMed ID: 31502893
    [No Abstract]   [Full Text] [Related]  

  • 27. Mapping the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D utility scores.
    Kay S; Ferreira A
    Ophthalmic Epidemiol; 2014 Apr; 21(2):66-78. PubMed ID: 24568628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenges Associated with Estimating Utility in Wet Age-Related Macular Degeneration: A Novel Regression Analysis to Capture the Bilateral Nature of the Disease.
    Hodgson R; Reason T; Trueman D; Wickstead R; Kusel J; Jasilek A; Claxton L; Taylor M; Pulikottil-Jacob R
    Adv Ther; 2017 Oct; 34(10):2360-2370. PubMed ID: 29019023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Sharma S; Brown GC; Brown MM; Hollands H; Shah GK
    Ophthalmology; 2001 Nov; 108(11):2051-9. PubMed ID: 11713079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the DRCR Retina Network Approach to Management With Initial Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity: A Secondary Analysis of a Randomized Clinical Trial.
    Glassman AR; Baker CW; Beaulieu WT; Bressler NM; Punjabi OS; Stockdale CR; Wykoff CC; Jampol LM; Sun JK;
    JAMA Ophthalmol; 2020 Apr; 138(4):341-349. PubMed ID: 32077907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visual Impairment and Blindness Avoided with Ranibizumab in Hispanic and Non-Hispanic Whites with Diabetic Macular Edema in the United States.
    Varma R; Bressler NM; Doan QV; Danese M; Dolan CM; Lee A; Turpcu A
    Ophthalmology; 2015 May; 122(5):982-9. PubMed ID: 25670501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of dexamethasone and triamcinolone for the treatment of diabetic macular oedema in Finland: A Markov-model.
    Pesonen M; Kankaanpää E; Vottonen P
    Acta Ophthalmol; 2021 Nov; 99(7):e1146-e1153. PubMed ID: 33421332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visual impairment as a function of visual acuity in both eyes and its impact on patient reported preferences.
    Finger RP; Fenwick E; Hirneiss CW; Hsueh A; Guymer RH; Lamoureux EL; Keeffe JE
    PLoS One; 2013; 8(12):e81042. PubMed ID: 24339893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Converting visual acuity to utilities.
    Sharma S; Brown GC; Brown MM; Shah GK; Snow K; Brown H; Hollands H
    Can J Ophthalmol; 2000 Aug; 35(5):267-72. PubMed ID: 10959467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monotherapy laser photocoagulation for diabetic macular oedema.
    Jorge EC; Jorge EN; Botelho M; Farat JG; Virgili G; El Dib R
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010859. PubMed ID: 30320466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incremental cost-effectiveness of screening and laser treatment for diabetic retinopathy and macular edema in Malawi.
    Vetrini D; Kiire CA; Burgess PI; Harding SP; Kayange PC; Kalua K; Msukwa G; Beare NAV; Madan J
    PLoS One; 2018; 13(1):e0190742. PubMed ID: 29300755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the relationship between visual acuity and central retinal (macular) thickness after interventions for macular oedema in diabetics: a review.
    Bong A; Doughty MJ; Button NF; Mansfield DC
    Clin Exp Optom; 2016 Nov; 99(6):491-497. PubMed ID: 27320640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vision-related quality of life in patients with diabetic macular oedema.
    Hariprasad SM; Mieler WF; Grassi M; Green JL; Jager RD; Miller L
    Br J Ophthalmol; 2008 Jan; 92(1):89-92. PubMed ID: 17584999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline predictors for visual acuity loss during observation in diabetic macular oedema with good baseline visual acuity.
    Busch C; Okada M; Zur D; Fraser-Bell S; Rodríguez-Valdés PJ; Cebeci Z; Lupidi M; Fung AT; Gabrielle PH; Giancipoli E; Chaikitmongkol V; Laíns I; Santos AR; Kunavisarut P; Sala-Puigdollers A; Chhablani J; Ozimek M; Hilely A; Degenhardt V; Loewenstein A; Iglicki M; Rehak M;
    Acta Ophthalmol; 2020 Nov; 98(7):e801-e806. PubMed ID: 32115886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient-reported utilities in bilateral visual impairment from amblyopia and age-related macular degeneration.
    van de Graaf ES; Despriet DDG; Klaver CCW; Simonsz HJ
    BMC Ophthalmol; 2016 May; 16(1):56. PubMed ID: 27184381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.